Form 4: Tempus AI CEO Eric Lefkofsky Sells Shares to Cover Tax Obligations

Tempus AI CEO and Chairman Eric Lefkofsky sold a portion of his Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Eric Lefkofsky, CEO and Chairman of Tempus AI, sold shares of Class A Common Stock between January 29, 2025 and January 31, 2025.
• The sales were conducted to cover statutory tax withholding obligations associated with the vesting of restricted stock units.
• The sales were not discretionary and were mandated by the company's equity incentive plan.
• A total of 238,790 shares were sold across multiple transactions at varying prices.
• The sales occurred at weighted average prices ranging from $53.77 to $59.86 per share.
• Lefkofsky still holds a significant number of shares both directly and indirectly through various entities.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock sales for tax purposes. It doesn't indicate any positive or negative sentiment about the company's performance or future outlook.

Positives

• The sales were not discretionary and were mandated by the company's equity incentive plan, indicating a standard process for handling tax obligations.
• The disclosure provides transparency regarding the transactions.

Negatives

• The sales resulted in a decrease in Lefkofsky's direct holdings of Class A Common Stock.

Risks

• While the sales were for tax obligations, large sales by insiders can sometimes be perceived negatively by the market.
• Continued sales by insiders could potentially put downward pressure on the stock price.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade company stock. It is a routine disclosure and does not indicate any unusual activity.

Comparison to Industry Standards

• The sale of shares to cover tax obligations is a common practice among executives at publicly traded companies.
• Similar filings are regularly made by insiders at companies like Illumina, Exact Sciences, and Guardant Health, which are also in the healthcare technology space.
• The volume of shares sold is not unusual for an executive with significant holdings.

Stakeholder Impact

• The stock sales may have a minor impact on the share price, but the transactions are not indicative of any change in the company's fundamentals.
• The sales do not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Tempus AI, Eric Lefkofsky, insider trading, Form 4, stock sale, tax obligations, restricted stock units, equity incentive plan, Class A Common Stock